| First Author | Logan T | Year | 2017 |
| Journal | Nat Neurosci | Volume | 20 |
| Issue | 5 | Pages | 681-689 |
| PubMed ID | 28288128 | Mgi Jnum | J:244405 |
| Mgi Id | MGI:5913184 | Doi | 10.1038/nn.4529 |
| Citation | Logan T, et al. (2017) alpha-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci 20(5):681-689 |
| abstractText | The protein alpha-synuclein has a central role in the pathogenesis of Parkinson's disease. Like that of other proteins that accumulate in neurodegenerative disease, however, the function of alpha-synuclein remains unknown. Localization to the nerve terminal suggests a role in neurotransmitter release, and overexpression inhibits regulated exocytosis, but previous work has failed to identify a clear physiological defect in mice lacking all three synuclein isoforms. Using adrenal chromaffin cells and neurons, we now find that both overexpressed and endogenous synuclein accelerate the kinetics of individual exocytotic events, promoting cargo discharge and reducing pore closure ('kiss-and-run'). Thus, synuclein exerts dose-dependent effects on dilation of the exocytotic fusion pore. Remarkably, mutations that cause Parkinson's disease abrogate this property of alpha-synuclein without impairing its ability to inhibit exocytosis when overexpressed, indicating a selective defect in normal function. |
